Skip to content.

Metabolic Syndrome Institute

You are here: Home » News » Lower high-density lipoprotein cholesterol levels correlate with adverse prognosis in patients with advanced heart failure


Lower high-density lipoprotein cholesterol levels correlate with adverse prognosis in patients with advanced heart failure

Document Actions
  • Print this page
2009-october-23

To evaluate the prognostic value of high-density lipoprotein cholesterol (HDL-C) levels in advanced heart failure (HF), 132 consecutive patients listed for heart transplantation were stratified by underlying aetiology (ischaemic vs non-ischaemic) and followed up for the primary composite end-points of HF hospitalisation or death. Survival analysis using Cox proportional hazard model revealed that reduced HDL-C (<33 mg/dL) was the most significant predictor of HF hospitalisation or death, irrespective of HF aetiology, whereas low cholesterol and low-density lipoprotein cholesterol alone were not shown to be independent outcome predictors. Thus, low HDL-C levels predict clinical worsening or death in advanced HF patients. Further research will determine whether low HDL-C is an emerging marker or a modifiable risk factor for this condition.

Abstract

Keywords:
HDL cholesterol – Heart failure

Ongoing Trials
Metabolic Syndrome Institute Landmark Studies
Guidelines
Metabolic Syndrome Institute Guidelines
Cardiovascular risks calculators
Metabolic Syndrome Institute Cardiovascular risks calculators
How to measure your waistline ?
Metabolic Syndrome Institute Measure your waistline
MSI Meeting
Newsletter

What's new ?
MSI special session at WCC 2008
Web Conference
Metabolic Syndrome Institute Web Conferences
 

This site conforms to the following standards: